7 completed, 6 unknown, 1 recruiting, 1 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 7, Unknown 6, Recruiting 1, Terminated 1 |
Follow PEG-rhG-CSF: new trials by email Literature Review of PEG-rhG-CSF trials Research Report on PEG-rhG-CSF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF PEG-rhG-CSF - Granulocyte Colony-stimulating Factor, Stem Cell Mobilization | Phase 4 | Unknown | Ning Huang | 80 | 2022-06-30 | 2022-06-16 |
| Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells PEG-rhG-CSF, RhG-CSF - Lymphoma | Phase 4 | Unknown | Chongqing University Cancer Hospital | 174 | 2022-03-01 | 2023-09-07 |
| Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer PEG-rhG-CSF - Breast Cancer, Neutropenia | Phase 4 | Completed | Peking University | 104 | 2019-08-01 | 2020-10-28 |
| Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma PEG-rhG-CSF, rhG-CSF - Lymphoma, Non-Hodgkin, Granulocyte Colony-Stimulating Factor | Phase 4 | Unknown | Ruijin Hospital | 250 | 2019-08-01 | 2019-09-10 |
| Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer PEG-rhG-CSF - Adjuvant Chemotherapy, Ovarian Neoplasms | Phase 4 | Terminated | Shandong University | 68 | 2017-12-01 | 2024-01-05 |
| To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer PEG-rhG-CSF, rhG-CSF - Cervical Cancer | Phase 4 | Unknown | Air Force Military Medical University, China | 20 | 2017-08-01 | 2017-08-28 |
| The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy PEG-rhG-CSF - Breastcancer | Phase 4 | Completed | Peking University | 240 | 2016-09-08 | 2019-01-18 |
| The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy PEG-rhG-CSF - Mammary Cancer, Lymphoma | Phase 4 | Unknown | Peking University | 217 | 2016-06-01 | 2016-09-19 |
| Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease Bortezomib, Eltrombopag, Imatinib - Hematological Neoplasms | Phase 4 | Recruiting | Wei Zhao | 1500 | 2016-01-31 | 2025-03-30 |
| PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation PEG-rhG-CSF, rhG-CSF - Lymphoma | Phase 4 | Unknown | Peking University | 96 | 2015-12-01 | 2016-09-19 |
| The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents PEG-rhG-CSF - Acute Lymphoid Leukemia | Phase 4 | Completed | Chinese Academy of Medical Sciences | 9 | 2015-09-01 | 2016-11-03 |
| PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy PEG-rhG-CSF - Lymphoma | Phase 4 | Completed | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 410 | 2013-09-01 | 2016-06-20 |
| PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy PEG-rhG-CSF - Malignant Solid Tumors | Phase 4 | Completed | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 420 | 2013-04-01 | 2016-06-17 |
| PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy PEG-rhG-CSF, rhG-CSF - Breast Cancer | Phase 4 | Completed | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 215 | 2013-04-01 | 2016-06-20 |
| PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia PEG-rhG-CSF - Breast Cancer | Phase 4 | Completed | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 484 | 2013-04-01 | 2016-06-20 |
Breast Neoplasms (4) · Lymphoma (4) · Bone Neoplasms (1) · Hematologic Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Neutropenia (1) · Ovarian Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Uterine Cervical Neoplasms (1)
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (4) · Peking University (4) · Air Force Military Medical University, China (1) · Chinese Academy of Medical Sciences (1) · Chongqing University Cancer Hospital (1) · Ning Huang (1) · Ruijin Hospital (1) · Shandong University (1) · Wei Zhao (1)
China (10)
Jun Zhu (1) · Jun Zhu, MD (1) · Mei Shi, MD (1) · Tao Ouyang, MD (1) · Wei Zhao, Ph.D (1) · Xiaofan Zhu, MD (1)